Scrambled control peptide for ZIP. Actsa as a PKMζ inhibitor.
CAT No: R0942
CAS No:908012-18-0
Synonyms/Alias:z-Pseudosubstrate inhibitory peptide (scrambled)
ZIP (Scrambled) is a synthetic peptide analog designed as a negative control for studies involving the zeta inhibitory peptide (ZIP), which specifically targets the atypical protein kinase C (aPKC) isoforms, particularly PKMζ. As a scrambled sequence that maintains the same amino acid composition as the active ZIP peptide but with a randomized order, ZIP (Scrambled) is biochemically inert with respect to aPKC inhibition. This characteristic makes it an essential tool for peptide-based research, enabling scientists to distinguish specific biological effects of ZIP from those arising due to nonspecific peptide interactions. By serving as a rigorous experimental control, ZIP (Scrambled) enhances the interpretive clarity of studies investigating synaptic plasticity, memory mechanisms, and signaling pathways modulated by PKMζ and related kinases.
Control validation in peptide research: ZIP (Scrambled) is widely employed as a negative control in experiments utilizing ZIP to assess the specificity of observed biological effects. Its use ensures that any functional changes, such as alterations in long-term potentiation or synaptic signaling, are attributable to the sequence-specific inhibition of aPKC isoforms rather than nonspecific actions of peptide administration. By providing a structurally similar but functionally inactive counterpart, it allows researchers to validate the mechanistic basis of their findings and rule out confounding variables associated with peptide delivery or uptake.
Mechanistic studies of protein kinase C signaling: In investigations of intracellular signaling cascades involving aPKC, particularly PKMζ, the scrambled peptide plays a critical role in differentiating between specific and nonspecific effects. When included alongside the active ZIP peptide, it helps clarify whether observed modulations in kinase activity, substrate phosphorylation, or downstream gene expression result from targeted inhibition or are artifacts of peptide presence. This distinction is vital for elucidating the genuine molecular underpinnings of PKC-mediated processes.
Neuroscience research and synaptic plasticity assays: ZIP (Scrambled) is frequently incorporated into studies exploring the molecular basis of memory, learning, and synaptic strength. By serving as a control, it enables rigorous assessment of ZIP's role in modulating long-term potentiation, long-term depression, and other forms of synaptic plasticity. Its inclusion in electrophysiological recordings and behavioral paradigms strengthens the validity of conclusions regarding the involvement of PKMζ in memory maintenance and neural circuitry remodeling.
Peptide uptake and delivery assessment: The scrambled sequence is valuable for evaluating the efficiency and specificity of peptide delivery systems in cellular or tissue models. By tracking the cellular uptake, distribution, and stability of ZIP (Scrambled), researchers can optimize experimental protocols and ensure that observed biological responses are due to the intended peptide activity rather than differences in delivery or peptide degradation. This application is particularly relevant for developing reliable methodologies in peptide-based signaling studies.
Assay optimization and background signal assessment: In biochemical and cell-based assays, ZIP (Scrambled) is used to measure background signals and nonspecific effects associated with peptide addition. Its inclusion helps distinguish between genuine target-specific interactions and assay artifacts, thereby improving the reliability and reproducibility of experimental data. By enabling accurate normalization and control, the scrambled peptide supports the development of robust protocols for studying kinase signaling and related cellular pathways.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More